Cover Page. The handle holds various files of this Leiden University dissertation
|
|
- Kenneth Greer
- 8 years ago
- Views:
Transcription
1 Cover Page The handle holds various files of this Leiden University dissertation Author: Klop, Boudewijn Title: Interplay between lipoproteins, the complement system and blood cells in atherosclerosis Issue Date:
2 Chapter 11 Additional information
3
4 Additional information 171 List of publications M.A. de Vries, B. Klop, S.A. Eskes, T.L.J.M. van der Loos, F.J.M. Klessens-Godfroy, J. Wiebolt, H.W. Janssen, E.M. Westerman, M. Castro Cabezas. The postprandial situation as a proinfammatory condition. Clin Investig Arterioscler 2014, in press M.A. de Vries, B. Klop, M. Castro Cabezas. The use of the non-fasting lipid profile in lipidlowering therapy in clinical practice: Point of view. Atherosclerosis 2014;234: B. Klop, G.J.M. van de Geijn, E. Birnie, T.L. Njo, H.W. Janssen, H.G. Jansen, J.W. Jukema, J.W.F. Elte, M. Castro Cabezas. Gender differences in vitamin D3 mediated effects on postprandial leukocyte activation and arterial stiffness. Eur J Clin Nutr 2014;68: P.W. Raess, G.J.M. van de Geijn, T.L. Njo, B. Klop, D. Sukhachev, G. Wertheim, T. McAleer, S.R. Master, A. Bagg. Automated screening for myelodysplastic syndromes through analysis of complete blood count and cell population data parameters. Am J Hematol 2014;89: B. Klop, C. Verseyden, J. Ribalta, J. Salazar, L. Masana, M. Castro Cabezas. MTP gene polymorhisms and postprandial lipemia in familial combined hyperlipidemia: effects of treatment with atorvastatin. Clin Investig Arterioscler 2014;26:49-56 A. Torres do Rego, B. Klop, E. Birnie, J.W.F. Elte, V. Cachofeiro Ramos, L.A. Alvarez-Sala Walther, M. Castro Cabezas. Diurnal triglyceridemia in relation to alcohol intake in men. Nutrients 2013;5: D.F. van Breukelen-van der Stoep, B. Klop, D. van Zeben, J.M.W. Hazes, M. Castro Cabezas. Cardiovascular risk in rheumatoid arthritis: how to lower the risk? Atherosclerosis 2013;231: Van Ramshorst GH, Klop B, Hop WC, Israelsson LA, Lange JF. Closure of midline laparotomies by means of small stitches: practical aspects of a new technique. Surg Technol Int 2013;23:23-30 B. Klop, G.J.M. van de Geijn, S.A. Bovenberg, N. van der Meulen, J.W.F. Elte, E. Birnie, T.L. Njo, J.W. Janssen, A. van Miltenburg, J.W. Jukema, M. Castro Cabezas. Erythrocyte-bound apolipoprotein B in relation to atherosclerosis, serum lipids and ABO blood group. PLoS One 2013;8:e75573
5 172 Chapter 11 B. Klop, G.J.M. van de Geijn, T.L. Njo, J.W. Janssen, A.P. Rietveld, A. van Miltenburg, L. Fernández-Sender, J.W.F. Elte, M. Castro Cabezas. Leukocyte cell population data (VCS) in postprandial leukocyte activation. Int J Lab Hematol 2013;35: B. Klop, J.W.F. Elte, M. Castro Cabezas. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients 2013;5: B. Klop, A. Torres do Rego, M. Castro Cabezas. Alcohol and plasma triglycerides. Curr Opin Lipidol 2013;24: M. Castro Cabezas, J.P.H. van Wijk, J.W.F. Elte, B. Klop. Effects of metformin on the regulation of free fatty acids in insulin resistance: a double blind, placebo controlled study. J Nutr Metab 2012;2012: B. Klop, J.W. Jukema, T.J. Rabelink, M. Castro Cabezas. A physician s guide for the management of hypertriglyceridemia: the etiology of hypertriglyceridemia determines treatment strategy. Panminerva Med 2012;54: B. Klop, M. Castro Cabezas. Chylomicrons: a key biomarker and risk factor of cardiovascular disease and for the understanding of obesity. Curr Cardiovasc Risk Rep, 2012;6:27-34 B. Klop, S.D. Proctor, J.C. Mamo, K.M. Botham, M. Castro Cabezas. Understanding postprandial inflammation and its relationship to lifestyle behaviour and metabolic diseases. Int J Vasc Med 2012;2012: S.A. Bovenberg, B. Klop, A. Alipour, S. Martinez-Hervas, A. Westzaan, G.J.M. van de Geijn J.W. Janssen, T. Njo, E. Birnie, R. van Mechelen, A.P. Rietveld, J.W.F. Elte, M. Castro Cabezas. Erythrocyte-associated apolipoprotein B and its relationship with clinical and subclinical atherosclerosis. Eur J Clin Invest 2012;42: B. Klop, T.M. van de Berg, A.P. Rietveld, J. Chaves, J.T. Real, J.F. Ascaso, R. Carmena, J.W.F. Elte, M. Castro Cabezas. AT1 receptor gene polymorphisms in relation to postprandial lipemia. Int J Vasc Med 2012;2012: B. Klop, J.S. Cohn, A.J.H.H.M. van Oostrom, J.P.H. van Wijk, E. Birnie, M. Castro Cabezas. Daytime triglyceride variability in men and women with different levels of triglyceridemia. Clin Chim Acta 2011;412:
6 Additional information 173 B. Klop, M.G. Scheffer, E. McFadden, F. Bracke, B. van Gelder. Treatment of pacemakerinduced superior vena cava syndrome by balloon angioplasty and stenting. Neth Heart J 2011;19:41-46 B. Klop, J.W.F. Elte, M. Castro Cabezas. Cholesterolhomeostase en enterohepatische connectie: nieuwe inzichten in cholesterolabsorptie. Ned Tijdschr Geneeskd 2010;154:A2503
7
8 Additional information 175 Curriculum vitae The author of this thesis was born in Woerdense Verlaat on February the 26 th In 2002 he graduated from the Coornhert Gymnasium and started medical school at the Erasmus University in Rotterdam the same year. During his last year of medical training he investigated the implementation of a new surgical technique to close abdominal wounds at the surgical department of the Erasmus MC and Sundsvall Hospital (Sweden) under supervision of prof. dr. L.A. Israelsson, prof. dr. J.F. Lange and dr. G.H. van Ramshorst. This experience provoked his interest for medical research and showed him the available scientific possibilities of non-academic hospitals. After receiving his medical degree in October 2008 he started as a cardiology resident at the Maasstad Ziekenhuis in Rotterdam until April In May 2010, Boudewijn started his work on this thesis at the department of Internal medicine of the Sint Franciscus Gasthuis in Rotterdam. He was supervised by dr. M. Castro Cabezas en dr. J.W.F. Elte in collaboration with prof. dr. J.W. Jukema from the department of Cardiology from the Leiden University Medical Center. The majority of the research described in this thesis was performed in close collaboration with the department of Clinical Chemistry at the Sint Franciscus Gasthuis itself (dr. J.W. Janssen, drs. T.L. Njo and dr. G.J.M. van de Geijn). Part of the research was also performed at the department of Nephrology at the Leiden University Medical Center (prof. dr. C. van Kooten and prof. dr. T.J. Rabelink) and at Sanquin in Amsterdam (dr. R. van Bruggen). After finishing his research in May 2013, he started as a cardiology resident at the Erasmus MC and started his specialty training in Cardiology in April 2014, which takes part in the Albert Schweitzer Hospital (dr. E.F.H. van Bommel and dr. M.J.M. Kofflard) and Erasmus MC (dr. J.W. Deckers and dr. T.W. Galema). Besides being a physician, Boudewijn likes to make sculptures as a hobby. The sculpture shown throughout this thesis was specially crafted by the author to illustrate the described research.
Role of Body Weight Reduction in Obesity-Associated Co-Morbidities
Obesity Role of Body Weight Reduction in JMAJ 48(1): 47 1, 2 Hideaki BUJO Professor, Department of Genome Research and Clinical Application (M6) Graduate School of Medicine, Chiba University Abstract:
More informationLIST OF PUBLICATIONS
LIST OF PUBLICATIONS List of publications 166 List of publications Papers van der Lugt JC, Valstar ER, Witvoet-Braam SW, Nelissen, RG. Migration of the humeral component of the Souter-Strathclyde elbow
More informationEPA/DHA Omega-3 Fatty Acids in the Primary and Secondary Prevention of Cardiovascular Disease and the Modification of Risk Factors
EPA/DHA Omega-3 Fatty Acids in the Primary and Secondary Prevention of Cardiovascular Disease and the Modification of Risk Factors Author: Bruce Holub, Ph.D. University Professor Emeritus (University of
More informationPrimary Care Management of Women with Hyperlipidemia. Julie Marfell, DNP, BC, FNP, Chairperson, Department of Family Nursing
Primary Care Management of Women with Hyperlipidemia Julie Marfell, DNP, BC, FNP, Chairperson, Department of Family Nursing Objectives: Define dyslipidemia in women Discuss the investigation process leading
More informationBody Composition & Longevity. Ohan Karatoprak, MD, AAFP Clinical Assistant Professor, UMDNJ
Body Composition & Longevity Ohan Karatoprak, MD, AAFP Clinical Assistant Professor, UMDNJ LONGEVITY Genetic 25% Environmental Lifestyle Stress 75% BMI >30 OBESE 25-30 OVERWEIGHT 18-25 NORMAL WEIGHT 18
More informationHow To Treat Dyslipidemia
An International Atherosclerosis Society Position Paper: Global Recommendations for the Management of Dyslipidemia Introduction Executive Summary The International Atherosclerosis Society (IAS) here updates
More informationThe early history of research on the Metabolic Syndrome
Lund 3 rd November 2006 The early history of research on the Metabolic Syndrome Peter Nilsson, MD, PhD Department of Clinical Sciences Medicine University Hospital MAS, Malmö Department for History of
More informationThe first endoscopically-delivered device therapy for obese patients with type 2 diabetes
DIABETES WEIGHT ENDOBARRIER THERAPY The first endoscopically-delivered device therapy for obese patients with type 2 diabetes Restore the metabolic health of your patients with EndoBarrier Therapy. Dual
More informationCover Page. The handle http://hdl.handle.net/1887/30207 holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/30207 holds various files of this Leiden University dissertation Author: Rodrigues, Sharon Priscilla Title: Towards safety in minimally invasive surgery
More informationLDL PARTICLE SIZE: DOES IT MATTER? Samia Mora, M.D., M.H.S., Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts.
LDL PARTICLE SIZE: DOES IT MATTER? Samia Mora, M.D., M.H.S., Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts Introduction While both small and large LDL particles may be atherogenic,
More informationINSULIN RESISTANCE AND COMPENSATORY HYPERINSULINEMIA: THE LINCHPIN BETWEEN OBESITY AND CARDIOVASCULAR DISEASE
May 2008 (Vol. 1, Issue 2, pages 4-10) INSULIN RESISTANCE AND COMPENSATORY HYPERINSULINEMIA: THE LINCHPIN BETWEEN OBESITY AND CARDIOVASCULAR DISEASE By Gerald M. Reaven, MD, Division of Cardiovascular
More informationCV MT Hoogwegt November 2012-1 - Curriculum vitae. Personal details. Madelein T. Hoogwegt
CV MT Hoogwegt November 2012-1 - Curriculum vitae Personal details Name Gender Date and place of birth Nationality Contact address Madelein T. Hoogwegt Female July 17, 1985, Venlo, The Netherlands Dutch
More informationDiabetes and Stroke. Understanding the connection between diabetes and the increased risk of stroke
Diabetes and Stroke Understanding the connection between diabetes and the increased risk of stroke Make the Connection Almost 26 million people in the U.S. roughly 8 percent of the population have diabetes.
More informationEffects of macronutrients on insulin resistance and insulin requirements
Effects of macronutrients on insulin resistance and insulin requirements Dr Duane Mellor RD Assistant Professor in Dietetics, The University of Nottingham, UK Outline of Discussion Issues of determining
More informationMetabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007
Metabolic Syndrome Overview: Easy Living, Bitter Harvest Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007 Evolution of Metabolic Syndrome 1923: Kylin describes clustering
More informationHow To Know If Coffee Increases Type 2 Diabetes Risk
help in type 2 diabetes risk reduction? 14th November 2013 Contents Page 1 Introduction 2 2 Epidemiological evidence 3 3 Clinical intervention trials 4 4 Clinical parameters 5 5 Underlying mechanisms 6
More informationTHE THIRD REPORT OF THE EXpert
SPECIAL COMMUNICATION Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
More informationArchive of SID. Hyperlipidemia After Kidney Transplantation Long-term Graft Outcome. Transplantation. www.sid.ir 49.
Transplantation Hyperlipidemia After Kidney Transplantation Long-term Graft Outcome Ghanbarali Raees-Jalali, Ahad Eshraghian, Alireza Faghihi, Jamshid Roozbeh, Mohammad Mehdi Sagheb, Hamed Eshraghian,
More informationEducation. Panel. Triglycerides & HDL-C
Triglycerides & HDL-C Thomas Dayspring, MD, ACP Clinical Assistant Professor of Medicine University of Medicine and Dentistry of New Jersey Attending in Medicine: St Joseph s s Hospital, Paterson, NJ Certified
More informationRobert Krysiak, Anna Gdula-Dymek, Bogus³aw Okopieñ
Pharmacological Reports 2013, 65, 429 434 ISSN 1734-1140 Copyright 2013 by Institute of Pharmacology Polish Academy of Sciences Lymphocyte-suppressing, endothelial-protective and systemic anti-inflammatory
More informationF fusion of Cytosolic Droplets and Insulin Resistance to Lung Cancer
Cytosolic lipid droplets: link to the development of insulin resistance and increased production of VLDL1 Sven-Olof Olofsson, MD, PhD Insulin resistance is an important risk factor for the development
More informationCURRICULUM VITAE. Jyrki K. Virtanen
CURRICULUM VITAE Jyrki K. Virtanen Date of birth: July 7, 1973 Address: 75 St. Alphonsus St., unit #1805 Place of birth: Hausjärvi, Finland Boston, MA 02120, USA Marital status: common-law marriage (Tulliportinkatu
More informationIsagenix Clinical Research Summary Suk Cho, Ph.D., Eric Gumpricht, Ph.D., David Despain, M.Sc.
Isagenix Clinical Research Summary Suk Cho, Ph.D., Eric Gumpricht, Ph.D., David Despain, M.Sc. UIC study finds subjects on Isagenix products lost more body fat, lost more visceral fat, showed greater adherence,
More information25-hydroxyvitamin D: from bone and mineral to general health marker
DIABETES 25 OH Vitamin D TOTAL Assay 25-hydroxyvitamin D: from bone and mineral to general health marker FOR OUTSIDE THE US AND CANADA ONLY Vitamin D Receptors Brain Heart Breast Colon Pancreas Prostate
More informationCan Common Blood Pressure Medications Cause Diabetes?
Can Common Blood Pressure Medications Cause Diabetes? By Nieske Zabriskie, ND High blood pressure, or hypertension, is a major risk factor for cardiovascular disease. In the United States, approximately
More informationNASH: It is not JUST a Fatty Liver. Karen F. Murray, M.D. Director of Hepatobiliary Program Children s Hospital and Regional Medical Center
NASH: It is not JUST a Fatty Liver Karen F. Murray, M.D. Director of Hepatobiliary Program Children s Hospital and Regional Medical Center Stages of Fatty Liver Disorders Fatty Liver 16-35% of Western
More informationProtein Intake in Potentially Insulin Resistant Adults: Impact on Glycemic and Lipoprotein Profiles - NPB #01-075
Title: Protein Intake in Potentially Insulin Resistant Adults: Impact on Glycemic and Lipoprotein Profiles - NPB #01-075 Investigator: Institution: Gail Gates, PhD, RD/LD Oklahoma State University Date
More informationVersion 1 2015. Module guide. Preliminary document. International Master Program Cardiovascular Science University of Göttingen
Version 1 2015 Module guide International Master Program Cardiovascular Science University of Göttingen Part 1 Theoretical modules Synopsis The Master program Cardiovascular Science contains four theoretical
More informationGetting Off the Chronic Disease Merry-Go-Round: What s the Weight of the Research?
Getting Off the Chronic Disease Merry-Go-Round: What s the Weight of the Research? Jody Dushay, MD MMSc Beth Israel Deaconess Medical Center Boston, MA Session 445 No disclosures Disclosure Jody Dushay,
More informationPantesin Effective support for heart healthy cholesterol levels*
Pantesin Effective support for heart healthy cholesterol levels* { Pantesin Effective support for heart healthy cholesterol levels* Many health-conscious adults keeping a watchful eye on their cholesterol
More informationYour Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007
Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007 The cardiometabolic risk syndrome is increasingly recognized
More informationPhD Education at Erasmus MC
PhD Education at Erasmus MC Research training in biomedical, clinical and health sciences Rita Struhkamp, Department of Research Policy FAQ s Where to start? Brochure Erasmus MC Graduate School www.erasmusmc.nl/phd
More informationGene A. Spiller, PhD, Antonella Dewell, MS, RD, Sally Chaves, RN, Zaga Rakidzich
TITLE Effect of daily use natural astaxanthin on C-reactive protein. Conducted by: Health Research & Studies Center, Los Altos, CA Gene A. Spiller, PhD, Antonella Dewell, MS, RD, Sally Chaves, RN, Zaga
More informationSecondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence
Guidelines Secondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence Stroke/TIA Nearly 700,000 ischemic strokes and 240,000 TIAs every year in the United States Currently, the risk for
More informationΗ δίαιτα στην πρόληψη του αγγειακού εγκεφαλικού επεισοδίου
ΠΡΟΓΡΑΜΜΑ ΜΕΤΑΠΤΥΧΙΑΚΩΝ ΣΠΟΥΔΩΝ «Η ΔΙΑΤΡΟΦΗ ΣΤΗΝ ΥΓΕΙΑ ΚΑΙ ΣΤΗ ΝΟΣΟ» Η δίαιτα στην πρόληψη του αγγειακού εγκεφαλικού επεισοδίου Γεώργιος Ντάιος Παθολογική Κλινική Πανεπιστημίου Θεσσαλίας Stroke Statistics
More informationAn Interview with Gerald Reaven: Syndrome X : The Risks of Insulin Resistance
An Interview with Gerald Reaven: Syndrome X : The Risks of Insulin Resistance Gerald Reaven, M.D., is Professor Emeritus (Active) of Medicine at Stanford University. He has served as director of the Division
More informationObesity in the United States Workforce. Findings from the National Health and Nutrition Examination Surveys (NHANES) III and 1999-2000
P F I Z E R F A C T S Obesity in the United States Workforce Findings from the National Health and Nutrition Examination Surveys (NHANES) III and 1999-2000 p p Obesity in The United States Workforce One
More informationYOUR GUIDE TO. Managing and Understanding Your Cholesterol Levels
YOUR GUIDE TO Managing and Understanding Your Cholesterol Levels Our goal at the Mercy Health Heart Institute is to help you be well. Our experienced team includes cardiologists, cardiovascular surgeons,
More informationCardiovascular Disease Risk Factors
Cardiovascular Disease Risk Factors Risk factors are traits and life-style habits that increase a person's chances of having coronary artery and vascular disease. Some risk factors cannot be changed or
More informationIR Conference Call on PCSK9
IR Conference Call on PCSK9 SAR236553/REGN727 PCSK9 Antibody for Hypercholesterolemia Phase 3 ODYSSEY Program Underway November 5, 2012 1 Safe Harbor Statement This presentation contains forward-looking
More informationTreatment of High Blood Cholesterol in Adults (Adult Treatment Panel II).
Complete Summary GUIDELINE TITLE (1)Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment
More informationROLE OF LDL CHOLESTEROL, HDL CHOLESTEROL AND TRIGLYCERIDES IN THE PREVENTION OF CORONARY HEART DISEASE AND STROKE
ROLE OF LDL CHOLESTEROL, HDL CHOLESTEROL AND TRIGLYCERIDES IN THE PREVENTION OF CORONARY HEART DISEASE AND STROKE I- BACKGROUND: Coronary artery disease and stoke are the major killers in the United States.
More informationInsulin Resistance and PCOS: A not uncommon reproductive disorder
Insulin Resistance and PCOS: A not uncommon reproductive disorder Joyce L. Ross, MSN, CRNP, CS, FNLA, FPCNA Diplomate Accrediation Council for Clinical Lipidology President Preventive Cardiovascular Nurses
More informationHeart Center Packages
Heart Center Packages For more information and appointments, Please contact The Heart Center of Excellence at the American Hospital Dubai Tel: +971-4-377-6571 Email: heartcenter@ahdubai.com www.ahdubai.com
More informationMen Sexual Dysfunction Associated with Obesity and Metabolic Syndrome
Men Sexual Dysfunction Associated with Obesity and Metabolic Syndrome By Aly A. Abbassy, MD, FACE Professor of Medicine (Endocrinology) Alexandria University My Talk will include: 1-Types of Men sexual
More informationDiabetes and Obesity. The diabesity epidemic
Diabetes and Obesity Frank B. Diamond, Jr. M.D. Professor of Pediatrics University of South Florida College of Medicine The diabesity epidemic Prevalence of diabetes worldwide was over 135 million people
More informationHabibollah Pirnejad MD., MSc., Ph.D., Post Doc.
Habibollah Pirnejad MD., MSc., Ph.D., Post Doc. Curriculum Vitae Health Information Technology group Tel: +98 441 2752305 Urmia Medical Science University Fax: +98 441 2770047 PO BOX: 1138 Email: h_pirnejad[at]yahoo.com
More informationHigh Blood Cholesterol
National Cholesterol Education Program ATP III Guidelines At-A-Glance Quick Desk Reference 1 Step 1 2 Step 2 3 Step 3 Determine lipoprotein levels obtain complete lipoprotein profile after 9- to 12-hour
More information4/4/2013. Mike Rizo, Pharm D, MBA, ABAAHP THE PHARMACIST OF THE FUTURE? METABOLIC SYNDROME AN INTEGRATIVE APPROACH
METABOLIC SYNDROME AN INTEGRATIVE APPROACH AN OPPORTUNITY FOR PHARMACISTS TO MAKE A DIFFERENCE Mike Rizo, Pharm D, MBA, ABAAHP THE EVOLUTION OF THE PHARMACIST 1920s 1960s 2000s THE PHARMACIST OF THE FUTURE?
More informationIS VITAMIN E SAFE TO USE?
Vitamin E & Fatty Liver IS VITAMIN E SAFE TO USE? Nonalcoholic Fatty Liver Disease (NAFLD) & Nonalcoholic Steatohepatitis (NASH) Prevalence: 5.7-16.5% 57 5 in US Usually diagnosed in 40-60 y/o s Non-significant
More informationVitamin D and Cardiometabolic risk
Vitamin D and Cardiometabolic risk 서울의대, 분당서울대병원 내과 최 성 희 2013년 대한당뇨병학회 춘계학술대회 Metabolism Of Vitamin D Risk factors for vitamin D deficiency - Aging decreased concentrations of 7-dehydro-cholesterol in
More informationYour healthcare provider has ordered a Boston Heart Cardiac Risk Assessment
Your healthcare provider has ordered a Boston Heart Cardiac Risk Assessment What does that mean for you? Your healthcare provider has determined that you may be at risk for cardiovascular disease (CVD).
More informationProposed FDA Rule To Ban Partially Hydrogenated (PHO) Oils. Johari Minal johari.usa@gmail.com
Proposed FDA Rule To Ban Partially Hydrogenated (PHO) Oils Johari Minal johari.usa@gmail.com Outline Chronology of events The harmful effects of trans fats The alternatives Background 1957 Fred Kummerow
More informationA Low-Carbohydrate as Compared with a Low-Fat Diet in Severe Obesity
The new england journal of medicine original article A Low-Carbohydrate as Compared with a Low-Fat in Severe Obesity Frederick F. Samaha, M.D., Nayyar Iqbal, M.D., Prakash Seshadri, M.D., Kathryn L. Chicano,
More informationIs Insulin Effecting Your Weight Loss and Your Health?
Is Insulin Effecting Your Weight Loss and Your Health? Teressa Alexander, M.D., FACOG Women s Healthcare Associates www.rushcopley.com/whca 630-978-6886 Obesity is Epidemic in the US 2/3rds of U.S. adults
More informationTYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D.
TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION Robert Dobbins, M.D. Ph.D. Learning Objectives Recognize current trends in the prevalence of type 2 diabetes. Learn differences between type 1 and type
More informationCORPORATE HEALTH LOWERING YOUR CHOLESTEROL & BLOOD PRESSURE
CORPORATE HEALTH LOWERING YOUR CHOLESTEROL & BLOOD PRESSURE What is Cholesterol? What s wrong with having high cholesterol? Major risk factor for cardiovascular disease Higher the cholesterol higher the
More informationMultiple comorbidities: additive and predictive of cardiovascular risk. Peter M. Nilsson Lund University University Hospital Malmö, Sweden
Multiple comorbidities: additive and predictive of cardiovascular risk Peter M. Nilsson Lund University University Hospital Malmö, Sweden Clinical outcomes: major complications of CVD Heart Attack/ACS
More informationDIABETES AND INSULIN RESISTANCE DIABETES PREVALANCE
DIABETES AND INSULIN RESISTANCE KARI KOHRS RD LDN CDE UICMC NUTRITION & WELLNESS CENTER DIABETES PREVALANCE Third leading cause of death-- United States 18 million diagnosed Growing at the rate of 3 new
More informationMY TYPE 2 DIABETES NUMBERS
BLOOD SUGAR MANAGEMENT GUIDE MY TYPE 2 DIABETES NUMBERS Understanding and Tracking the ABCs of Type 2 Diabetes 1 BLOOD MY TYPE SUGAR 2 DIABETES MANAGEMENT ABC NUMBERS GUIDE When you have type 2 diabetes,
More informationDiabetes and Heart Disease
Diabetes and Heart Disease Diabetes and Heart Disease According to the American Heart Association, diabetes is one of the six major risk factors of cardiovascular disease. Affecting more than 7% of the
More informationBarriers to Healthcare Services for People with Mental Disorders. Cardiovascular disorders and diabetes in people with severe mental illness
Barriers to Healthcare Services for People with Mental Disorders Cardiovascular disorders and diabetes in people with severe mental illness Dr. med. J. Cordes LVR- Klinikum Düsseldorf Kliniken der Heinrich-Heine-Universität
More informationFreiburg Study. The other 24 subjects had healthy markers closer to what would be considered ideal.
Freiburg Study The Freiburg Study was conducted with 48 healthy human subjects of various ages. None of the test subjects had been diagnosed with any disease prior to the study. None were taking any type
More informationPostprandial lipid metabolism
ænafa 26 Postprandial lipid metabolism Gabriele Riccardi, Lutgarda Bozzetto and Giovanni Annuzzi Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy Abstract Atherogenic
More informationSubject Index. Bariatric surgery, obesity management 134
Subject Index Acromegaly, PCOS differential diagnosis 149, 150, 154, 155 Adipokines, see specific adipokines Adiponectin, metabolic syndrome role 41 43 Adolescents, PCOS diagnosis 16, 17 Adrenal hyperplasia,
More informationOmega-3 Fatty Acid Products
Omega-3 Fatty Acid Products Policy Number: 5.01.563 Last Review: 7/2016 Origination: 6/2014 Next Review: 7/2017 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage for the
More informationVitamin D und seine Bedeutung im Immunsystem und bei der Infektabwehr
Vitamin D und seine Bedeutung im Immunsystem und bei der Infektabwehr Stefan Pilz Department of Internal Medicine, Division of Endocrinology and Metabolism, Medical University of Graz, Austria Department
More informationCardiology Department and Center for Research and Prevention of Atherosclerosis, Hadassah Hebrew University Medical Center.
CETP and IRS1 Genetic Variation Modulates Effects of Weight loss Diets on Lipid Profile in Two Independent 2 Year Diet Intervention Studies: The Pounds Lost and DIRECT Trails Ronen Durst, MD Cardiology
More informationPowerPoint Lecture Outlines prepared by Dr. Lana Zinger, QCC CUNY. 12a. FOCUS ON Your Risk for Diabetes. Copyright 2011 Pearson Education, Inc.
PowerPoint Lecture Outlines prepared by Dr. Lana Zinger, QCC CUNY 12a FOCUS ON Your Risk for Diabetes Your Risk for Diabetes! Since 1980,Diabetes has increased by 50 %. Diabetes has increased by 70 percent
More informationPlasma Testosterone Level in Male Patients with Metabolic Syndrome
Med. J. Cairo Univ., Vol. 77, No. 1, June: 351-357, 2009 www.medicaljournalofcairouniversity.com Plasma Testosterone Level in Male Patients with Metabolic Syndrome NASHWA EL-SARRAF, M.D. and AMR EL-HADIDY,
More informationACADEMIC APPOINTMENTS: 2009 to present - Assistant Professor of Mother and Child Health at Qazvin University of Medical Science
CURRICULUM VITAE Name: Sonia Oveisi Address: Qazvin University of Medical Science Qazvin- Iran Tel : 0281-3338034 Date of birth: 7 th Sep. 1971 Email: Soniaoveisi@yahoo.com soveisi@razi.tums.ac.ir EDUCATION:
More informationClinical Research on Lifestyle Interventions to Treat Obesity and Asthma in Primary Care Jun Ma, M.D., Ph.D.
Clinical Research on Lifestyle Interventions to Treat Obesity and Asthma in Primary Care Jun Ma, M.D., Ph.D. Associate Investigator Palo Alto Medical Foundation Research Institute Consulting Assistant
More informationCardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011
Cardiovascular disease physiology Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011 Content Introduction The number 1 killer in America Some statistics Recommendations The disease process
More informationHYPERCHOLESTEROLAEMIA STATIN AND BEYOND
HYPERCHOLESTEROLAEMIA STATIN AND BEYOND Andrea Luk Division of Endocrinology Department of Medicine & Therapeutics The Chinese University of Hong Kong HA Convention 4 May 2016 Statins reduce CVD and all-cause
More informationNancy S. Swayze. 2 ND YEAR RESEARCH ELECTIVE RESIDENT S JOURNAL Volume V, 2000-2001. A. Background
Efficacy Of Insulin Sensitizing Agents In Subjects With Metabolic Syndrome X And Impaired Glucose Tolerance After 6 Months Of Diet And Exercise Therapy Nancy S. Swayze A. Background Impaired glucose tolerance
More informationM.A.Lips. Copyright 2014, M.A.Lips, Amsterdam, the Netherlands
Roux-en-Y Gastric Bypass and Calorie Restriction: Differences and Similarities of Endocrine and Metabolic Effects in Obesity and Type 2 Diabetes Mellitus Mirjam Anne Lips Roux-en-Y Gastric Bypass and Calorie
More informationLong term Weight Management in Obese Diabetic Patients Osama Hamdy, MD, PhD, FACE
Long term Weight Management in Obese Diabetic Patients Osama Hamdy, MD, PhD, FACE Medical Director, Obesity Clinical Program, Director of Inpatient Diabetes Management, Joslin Diabetes Center Assistant
More informationDELIRIUM: DALLA DIAGNOSI AL TRATTAMENTO LE PROSPETTIVE DELLA RICERCA
DELIRIUM: DALLA DIAGNOSI AL TRATTAMENTO LE PROSPETTIVE DELLA RICERCA S.Govoni Delirium is an acute disorder of attention and cognition in elderly people that is common, serious, costly, underrecognised,
More informationType 2 Diabetes Mellitus and Insulin resistance syndrome in Children
Type 2 Diabetes Mellitus and Insulin resistance syndrome in Children Anil R Kumar MD Pediatric Endocrinology MCV/VCU, Richmond VA Introduction Type 2 diabetes mellitus (T2 DM) has increased in children
More informationReversing type 2 diabetes: pancreas composition and function during return to normal glucose tolerance
Reversing type 2 diabetes: pancreas composition and function during return to normal glucose tolerance Dr Sarah Steven Clinical Research Fellow to Professor Roy Taylor Observations from bariatric surgery
More informationThe WHI 12 Years Later: What Have We Learned about Postmenopausal HRT?
AACE 23 rd Annual Scientific and Clinical Congress (2014) Syllabus Materials: The WHI 12 Years Later: What Have We Learned about Postmenopausal HRT? JoAnn E. Manson, MD, DrPH, FACP, FACE Chief, Division
More informationCARDIAC CARE. Giving you every advantage
CARDIAC CARE Giving you every advantage Getting to the heart of the matter The Cardiovascular Program at Northwest Hospital & Medical Center is dedicated to the management of cardiovascular disease. The
More informationKIH Cardiac Rehabilitation Program
KIH Cardiac Rehabilitation Program For any further information Contact: +92-51-2870361-3, 2271154 Feedback@kih.com.pk What is Cardiac Rehabilitation Cardiac rehabilitation describes all measures used to
More informationHEALTH BENEFITS. Omega-3 Fish Oil
HEALTH BENEFITS Omega-3 Fish Oil Omega-3 fatty acids are essential polyunsaturated fats. They cannot be manufactured by the body and therefore must be consumed through food or supplements. Three types
More informationDIET AND EXERCISE STRATEGIES FOR WEIGHT LOSS AND WEIGHT MAINTENANCE
DIET AND EXERCISE STRATEGIES FOR WEIGHT LOSS AND WEIGHT MAINTENANCE 40 yo woman, BMI 36. Motivated to begin diet therapy. Which of the following is contraindicated: Robert B. Baron MD MS Professor and
More informationStrokes and High Blood Pressure
Strokes and High Blood Pressure Quick Review from last Week: What is a Stroke Stroke: blood supply to the brain is severely limited or cut off With no blood to carry oxygen to them, brain cells will die
More informationVascular Risk Reduction: Addressing Vascular Risk
Vascular Risk Reduction: Addressing Vascular Risk Vascular Risk Reduction (VRR) Welcome! Presentation & Activities Focus: Managing known risk factors for vascular disease. Engage, collaborate and have
More informationAntipsychotic Medications and the Risk of Diabetes and Cardiovascular Disease
Antipsychotic Medications and the Risk of Diabetes and Cardiovascular Disease Patient Tool #1 Understanding Diabetes and Psychiatric Illness: A Guide for Individuals, Families, and Caregivers Type 2 Diabetes,
More informationA COMPARATIVE STUDY OF THE FATTY ACID COMPOSITION OF FORTY MARGARINES AVAILABLE IN SOUTH AFRICA
1 A COMPARATIVE STUDY OF THE FATTY ACID COMPOSITION OF FORTY MARGARINES AVAILABLE IN SOUTH AFRICA Dr Carl Albrecht Head of Research Cancer Association of South Africa (CANSA) e-mail: calbrecht@cansa.org.za
More informationPrimary Care Guidance Program: Non-Alcohol related Fatty Liver Disease (NAFLD) Guidance on Management in Primary Care
Primary Care Guidance Program: Non-Alcohol related Fatty Liver Disease (NAFLD) Guidance on Management in Primary Care This advice has been developed to help GPs with shared care of patients with Non- Alcohol
More informationTYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY. Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU
TYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU Objectives: 1. To discuss epidemiology and presentation
More informationMediterranean diet: A heart-healthy eating plan Source: mayoclinic.org/mediterranean-diet
Mediterranean diet: A heart-healthy eating plan Source: mayoclinic.org/mediterranean-diet The heart-healthy Mediterranean is a healthy eating plan based on typical foods and recipes of Mediterranean-style
More informationHôpitaux Universitaires de Genève Lipides, métabolisme des hydrates de carbonne et maladies cardio-vasculaires
Hôpitaux Universitaires de Genève Lipides, métabolisme des hydrates de carbonne et maladies cardio-vasculaires Prof. J. Philippe Effect of estrogens on glucose metabolism : Fasting Glucose, HbA1c and C-Peptide
More informationESC/EASD Pocket Guidelines Diabetes, pre-diabetes and cardiovascular disease
Diabetes, prediabetes and cardiovascular disease Classes of recommendations Levels of evidence Recommended treatment targets for patients with diabetes and CAD Definition, classification and screening
More informationThe Diabetes Epidemic
The Diabetes Epidemic O 2118 Wilshire Blvd. Ste. 723 O Santa Monica, California 90403 O www.susandopart.com O susan@susandopart.com What to look for and how you can help your clients O 310-828-4476 Trends
More informationPublished Quarterly Mangalore, South India ISSN 0972-5997 Volume 4, Issue 1; January-March 2005
Published Quarterly Mangalore, South India ISSN 0972-5997 Volume 4, Issue 1; January-March 2005 Original Article Genetic Association Between Insulin Resistance And Total Cholesterol In Type 2 Diabetes
More informationThe largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38
Bayer HealthCare has announced the initiation of the COMPASS study, the largest clinical study of its oral anticoagulant Xarelto (rivaroxaban) to date, investigating the prevention of major adverse cardiac
More informationCORPORATE WELLNESS PROGRAM
CORPORATE WELLNESS PROGRAM WELLNESS Wellness has become an increasingly relevant issue in companies large and small as organizations have come to realize how proactively addressing health and wellness
More informationDIABETES YOUR GUIDE TO
YOUR GUIDE TO DIABETES b What is diabetes? b Type 2 diabetes prevention b Prevention checklist b Living with diabetes b Complications b Terms to know b Resources To promote and protect the health of Canadians
More informationTreating Patients with PRE-DIABETES David Doriguzzi, PA-C First Valley Medical Group. Learning Objectives. Background. CAPA 2015 Annual Conference
Treating Patients with PRE-DIABETES David Doriguzzi, PA-C First Valley Medical Group Learning Objectives To accurately make the diagnosis of pre-diabetes/metabolic syndrome To understand the prevalence
More information